CASTLE BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
CASTLE BIOSCIENCES, INC. (CSTL) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 2.15 million shares for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-09-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2019-09-03
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 2.15M shares, a 13.49% increase year-over-year.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-06-30 was 1.90M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month |
|---|---|---|
| 2019-06-30 | 2.15M shares 10-Q · filed 2019-09-03 | 2.04M shares 10-Q · filed 2019-09-03 |
| 2018-06-30 | 1.90M shares 10-Q · filed 2019-09-03 | 1.90M shares 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |